Thank you for this post

New Post Public Reply Private Reply Replies (0) Message Board
repok704
652
Friday, June 8, 2018 11:52:47 AM

Post#
7233
of 7261
(Total Views: 85)
Posted On: 06/08/2018 12:33:52 AM

Posted By: Schwa313
Re: The X #7232

Chris Kramer
Pharmacist
Jason, I appreciate you taking your time to answer my questions. All I can do is comment on the information available to me and other investors and to be frank, there is little to nothing. Investors are being ignored by IR. There have been no PRs for over 60 days, therefore we cannot rightly know what has been going on. Investors can only go based off of what we have been told and that was that marketing would be ongoing during Q2. Here we are, 23 days away from Q2 closing and there has been nothing, only silence. One could reasonably conclude that nothing is being done.

We are all aware that you read the trading forums, so you know that there are a lot of people who have lost a lot of money putting their faith in this company that has gone completely silent and continues to ignore them. We were promised transparency and what we have received is the exact opposite. You are in a unique position to make statements about having patience or that you're hard at work. I realize there are a lot of things you cannot tell us but put yourself in our shoes for a moment. Your IR "team" goes dark. The Twitter account won't respond to messages. Silence.




Jasons Reply
One could reasonably conclude a number of things by stringing along details and trying to fill in the blanks. There's a wide range of alternative facts that support a wide range of agendas. You're 100% right about me being in a unique position and also right that there are things that I cannot address to investors. I am a singular component of a team, and we prefer to move and speak as one. I understand that investors must make decisions based on the information made publicly available by the company and I apologize that there are boring non-news worthy aspects to aligning our business vision. People are looking for information that supports their individual agenda and the company wont pander or subscribe to those schemes. I think we can agree that a period of silence has forced our investor pool to really take a look at what the company has put out there and weigh the facts for themselves. I consider myself a man of vision and ambition. I've surrounded myself with intelligent and talented individuals who share that vision and ambition. I just have to say, if one subscribes to this theory that we came to the OTC to run a scam on people, that's "basic af".


Read More: https://investorshangout.com/post/view?id=507...z5HqjzuX00

Andiamo Corp (ANDI) Stock Research Links

ANDI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 14

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 19

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 18

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 17

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 15

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 20

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 15

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 10

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 18

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Flying Bikes Market Expansion: A Journey to New Heights

Updated Category News Views 155

Flying Bikes Market Growth Projections The global flying bikes market is currently on an impressive trajectory. Originally valued at US$ 80.6 billion, it is anticipated to reach an astounding US$ 377.5 billion by 2033, demonstrating a compound annual growth rate (CAGR) of 18.7% during this period. Innovative Performance Metrics Driving Demand Performance metrics for...

Continue Reading
Diversified Energy Enhances Portfolio with New Acquisition Deal

Updated Category News Views 205

Acquisition of Natural Gas Properties by Diversified Energy Bolt-on Acquisition Increases Coal Mine Methane Environmental Credit Cash Flow, Expands Midstream Infrastructure, and Enhances Southern Appalachia Prices Strategic Refinance Incorporates 40% Improvement in Cash Flow from New Hedges and an Innovative Master Trust Structure Solidifies Diversified as the Leading...

Continue Reading
MetroCity Bankshares and First IC Corporation Merge for Growth

Updated Category News Views 129

Strategic Merger of MetroCity Bankshares and First IC Corporation MetroCity Bankshares, Inc. (NASDAQ: MCBS) announced an exciting development as it has secured all necessary regulatory approvals for its merger with First IC Corporation (OTCEM: FIEB). This strategic combination aims to enhance their banking services and expand their operational footprint across several...

Continue Reading
Crown's Revenue Surges in First Quarter Financial Update

Updated Category News Views 178

Crown Electrokinetics Corp. Financial Performance Update Crown Electrokinetics Corp. (NASDAQ: CRKN) has recently released its financial results, marking significant developments for the first quarter of 2025. This summary includes insights into revenue growth, operational accomplishments, and strategic advancements that highlight the company’s evolving presence in the...

Continue Reading
Eileen Revamps Retail Dynamics with New Investment Boost

Updated Category News Views 6

Capital Surge Fuels Eileen's Ambitious Expansion Now, here's something that's bound to shake up the retail tech scene. Eileen Inc., a fresh face in retail technology, just grabbed a strategic investment from DisPact Ventures. This isn't just another drop in the bucket; it's throwing serious weight into their operations to gear up for a monstrous scale. The injection into...

Continue Reading